Entered into an underwriting agreement on May 6, 2026, for the sale of 9,859,155 shares of common stock. The public offering price was set at $71.00 per share. Underwriters exercised their over-allotment option in full on May 7, 2026, for an additional 1,478,873 shares. Total net proceeds are estimated at $760.2 million after deducting underwriting discounts, commissions, and estimated expenses. The offering was conducted under an automatic shelf registration statement originally filed in February 2025. As of May 5, 2026, the company had 124,432,565 shares of common stock outstanding prior to this issuance.